Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

Completed · Phase 2 · Has a placebo group

Conditions studied: Benign Prostatic Hyperplasia

In brief

The purpose of this study is to evaluate the safety and efficacy of various fixed daily doses of WC3055 compared with placebo for the treatment of subjects with LUTS secondary to BPH.

Key facts

Study ID
NCT01939184
Run by
Warner Chilcott
People needed
796
Starts
2013-08-01
Expected to finish
2014-04-01
Last updated by the study team
2015-06-29

Who can join

Age: 45 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.